Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

CMPX — Compass Therapeutics, Inc. Dilution Risk Tracker

Track CMPX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMPX — Get alerts when the score changes →

As of October 13, 2026, Compass Therapeutics, Inc. (CMPX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Compass Therapeutics, Inc. has a market capitalization of $168.92M, 180.09M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $400.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
92
💰 Cash Runway
0
📊 Float Risk
32
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($400M, 237% of market cap)
🔔 Track CMPX — Get forecast alerts →

Market Data

Market Cap$168.92M
Shares Outstanding180.09M
Float122.69M
Cash$179.88M
Debt$9.79M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding180.09MVerified float table or market cache
Public Float122.69MVerified float table or market cache
Market Cap$168.92MMarket data cache
Cash Runway38.1 monthsDilutionWatch score inputs
Shelf Capacity$400.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 3, SC 13G 1, SC 13G/A 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 102.14M shares
#1 Tang Capital Management, LLC 16.79M shares
#2 Orbimed Advisors LLC. 15.22M shares
#3 Suvretta Capital Management, LLC 14.31M shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest40.36M
Days to Cover6.3
% of Float32.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-03-05
4 INSIDER TRANSACTION 2026-10-02
4 INSIDER TRANSACTION 2026-09-25
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
SC 13G BENEFICIAL OWNERSHIP 2026-08-07
Full SEC filing analysis available with free account →

Recent News

Factual CMPX Dilution Snapshot

Compass Therapeutics, Inc. (CMPX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CMPX's DilutionScore is currently 43/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 38/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202643/100MEDIUM4 days
Jul 16 – Oct 09, 202638/100MEDIUM85 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CMPX shares outstanding have increased 1.3% from 177.86M (Mar 2026) to 180.09M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 2026180.09M122.69M▲ 0.43%
May 19, 2026180.09M122.16M▼ 0.10%
May 08, 2026180.09M122.29M▲ 2.91%
May 03, 2026180.09M118.83M▼ 0.03%
Mar 20, 2026180.09M118.87M▲ 0.02%
Mar 09, 2026177.86M118.85M▲ 0.65%
Mar 08, 2026177.86M118.08M▲ 1.25%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CMPX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CMPX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CMPX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CMPX
CMPX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.